Personalized treatment of sezary syndrome by targeting a novel ctla4:Cd28 fusion

Molecular Genetics and Genomic Medicine

Volumn 3, Issue 2, 2015, Pages 130-136

  Sekulic, Aleksandar ^a,b   Liang, Winnie S ^b   Tembe, Waibhav ^b   Izatt, Tyler ^b   Kruglyak, Semyon ^c   Kiefer, Jeffrey A ^b   Cuyugan, Lori ^b   Zismann, Victoria ^b   Legendre, Christophe ^b   Pittelkow, Mark R ^a   Gohmann, John J ^d   De Castro, Fernando R ^e   Trent, Jeffrey ^b   Carpten, John ^b   Craig, David W ^b   McDaniel, Timothy K ^f,g  

^a MAYO CLINIC   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c ILLUMINA INC   (United States)

^d Nephrology Associates of Lexington   (United States)

^e Dermatology Associates of Kentucky   (United States)

^f Derby Lane Farm ^*  (United States)

^g Ashion Analytics   (United States)

Author keywords

CD28; CTLA4; Sezary syndrome

Indexed keywords

EID: 84971513662     PISSN: None     EISSN: 23249269     Source Type: Journal    
DOI: 10.1002/mgg3.121     Document Type: Article

References (27)

1. Ahmed, N., M. Zeng, I. Sinha, L. Polin, W. Z. Wei, C. Rathinam, et al. 2011. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation. Nat. Immunol. 12:1176–1183. doi: 1110.1038/ni.2157
2. Bentley, D. R., S. Balasubramanian, H. P. Swerdlow, G. P. Smith, J. Milton, C. G. Brown, et al. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456:53–59. doi: 10.1038/nature07517
3. Craig, D.W., J.A.O’ Shaughnessy, J.A. Kiefer, J. Aldrich, S. Sinari, S. Sinari, et al. 2013. Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Mol. Cancer Ther. 12:104–116. doi: 110. 1158/1535-7163.MCT-1112-0781
4. Dennehy, K. M., F. Elias, G. Zeder-Lutz, X. Ding, D. Altschuh, F. Luhder, et al. 2006. Cutting edge: monovalency of CD28 maintains the antigen dependence of T cell costimulatory responses. J. Immunol. 176:5725–5729.
5. Hoff, H., P. Kolar, A. Ambach, A. Radbruch, and M. C. Brunner-Weinzierl. 2010. CTLA-4 (CD152) inhibits T cell function by activating the ubiquitin ligase Itch. Mol. Immunol. 47:1875–1881. doi: 10.1016/j.molimm.2010.03.017
6. Khattri, R., J. A. Auger, M. D. Griffin, A. H. Sharpe, and J. A. Bluestone. 1999. Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J. Immunol. 162:5784–5791.
7. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459–465.
8. Kueng, S., B. Hegemann, B. H. Peters, J. J. Lipp, A. Schleiffer, K. Mechtler, et al. 2006. Wapl controls the dynamic association of cohesin with chromatin. Cell 127:955–967.
9. Laharanne, E., E. Chevret, Y. Idrissi, C. Gentil, M. Longy, J. Ferrer, et al. 2010. CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma. Mod. Pathol. 23:547–558.
10. Li, J. Y., S. Horwitz, A. Moskowitz, P. L. Myskowski, M. Pulitzer, and C. Querfeld. 2012. Management of cutaneous T cell lymphoma: new and emerging targets and treatment options. Cancer Manag. Res. 4:75–89.
11. Morris, L. G., S. Veeriah, and T. A. Chan. 2010. Genetic determinants at the interface of cancer and neurodegenerative disease. Oncogene 29:3453–3464.
12. Mund, T., and H. R. Pelham. 2009. Control of the activity of WW-HECT domain E3 ubiquitin ligases by NDFIP proteins. EMBO Rep. 10:501–507.
13. Mund, T., and H. R. Pelham. 2010. Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2. Proc. Natl. Acad. Sci. USA 107:11429–11434.
14. Ohbayashi, T., K. Oikawa, K. Yamada, C. Nishida-Umehara, Y. Matsuda, H. Satoh, et al. 2007. Unscheduled overexpression of human WAPL promotes chromosomal instability. Biochem. Biophys. Res. Commun. 356:699–704.
15. Oliver, P. M., X. Cao, G. S. Worthen, P. Shi, N. Briones, M. MacLeod, et al. 2006. Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation. Immunity 25:929–940.
16. Olsen, E. A., A. H. Rook, J. Zic, Y. Kim, P. Porcu, C. Querfeld, et al. 2011. Sezary syndrome: immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). J. Am. Acad. Dermatol. 64:352–404.
17. Perry, W. L., C. M. Hustad, D. A. Swing, T. N. O’Sullivan, N. A. Jenkins, and N. G. Copeland. 1998. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in 18H mice. Nat. Genet. 18:143–146.
18. Poulogiannis, G., R. E. McIntyre, M. Dimitriadi, J. R. Apps, C. H. Wilson, K. Ichimura, et al. 2010. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proc. Natl. Acad. Sci. USA 107:15145–15150. doi: 15110. 11073/pnas.1009941107
19. Puente, X. S., M. Pinyol, V. Quesada, L. Conde, G. R. Ordonez, N. Villamor, et al. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475:101–105. doi: 110.1038/nature10113
20. Shembade, N., N. S. Harhaj, K. Parvatiyar, N. G. Copeland, N. A. Jenkins, L. E. Matesic, et al. 2008. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9:254–262.
21. Stephens, P. J., P. S. Tarpey, H. Davies, P. Van Loo, C. Greenman, D. C. Wedge, et al. 2012. The landscape of cancer genes and mutational processes in breast cancer. Nature 486:400–404. doi: 410.1038/nature11017
22. Tan, S. B., K. B. Dear, P. Bruzzi, and D. Machin. 2003. Strategy for randomised clinical trials in rare cancers. BMJ 327:47–49.
23. Tiacci, E., V. Trifonov, G. Schiavoni, A. Holmes, W. Kern, M. P. Martelli, et al. 2011. BRAF mutations in hairy-cell leukemia. N. Engl. J. Med. 364:2305–2315. doi: 2310.1056/NEJMoa1014209
24. Trapnell, C., L. Pachter, and S. L. Salzberg. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111.
25. Trapnell, C., B. A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M. J. van Baren et al. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28:511–515.
26. Veeriah, S., B. S. Taylor, S. Meng, F. Fang, E. Yilmaz, I. Vivanco, et al. 2010. Somatic mutations of the Parkinson’s disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat. Genet. 42:77–82. doi: 10.1038/ng. 1491
27. Yin, L., H. Schneider, and C. E. Rudd. 2003. Short cytoplasmic SDYMNM segment of CD28 is sufficient to convert CTLA-4 to a positive signaling receptor. J. Leukoc. Biol. 73:178–182.